206
Views
8
CrossRef citations to date
0
Altmetric
Original Articles

Medical, therapeutic, and recreational use of cannabis among young men who have sex with men living with HIV

, , , , , , & show all
Pages 250-259 | Received 03 Apr 2019, Accepted 05 Jun 2019, Published online: 26 Jun 2019

References

  • Abrams DI, Jay CA, Shade SB, Vizoso H, Reda H, Press S, Kelly ME, Rowbotham MC, Petersen KL. 2007. Cannabis in painful HIV-associated sensory neuropathy: A randomized placebo-controlled trial. Neurology. 68(7):515–521.
  • Alzghari SK, Fung V, Rickner SS, Chacko L, Fleming SW. 2017. To dab or not to dab: rising concerns regarding the toxicity of cannabis concentrates. Cureus. 9(9):e1676.
  • Bonn-Miller MO, Oser ML, Bucossi MM, Trafton JA. 2014. Cannabis use and HIV antiretroviral therapy adherence and HIV-related symptoms. J Behav Med. 37(1):1–10.
  • Braitstein P, Kendall T, Chan K, Wood E, Montaner JSG, O'Shaughnessy MV, Hogg RS. 2001. Mary-jane and her patients: sociodemographic and clinical characteristics of HIV-positive individuals using medical marijuana and antiretroviral agents. AIDS. 15(4):532–533.
  • Bronfenbrenner U. 1979. The ecology of human development. Cambridge, MA: Harvard University.
  • Brook JW, Stimmel MA, Zhang C, Brook DW. 2008. The association between earlier marijuana use and subsequent academic achievement and health problems: A longitudinal study. Am J Addict. 17(2):155–160.
  • Bruce D, Harper GW, Fernández MI, The ATN. 2013. Heavy marijuana use among gay and bisexual male emerging adults living with HIV/AIDS. J HIV AIDS Soc Svcs. 12(1):66–88.
  • Bruce D, Kahana SY, Bauermeister JA, Nichols SL, Hightow-Weidman LB, Heinze JE, Shea J, Fernández MI, The A. 2015. Neighborhood-level and individual-level correlates of cannabis use among adolescents and emerging adults living with HIV/AIDS. Drug Alcohol Depend. 151:173–180.
  • Bruce D, Stall R, Fata A, Campbell R. 2014. Modeling minority stress effects on homelessness and health disparities among young men who have sex with men. J Urban Health. 91(3):568–580.
  • Bujarski SJ, Norberg MM, Copeland J. 2012. The association between distress tolerance and cannabis use-related problems: The mediating and moderating roles of coping motives and gender. Addict Behav. 37(10):1181–1184.
  • Centers for Disease Control and Prevention. 2018. HIV/AIDS surveillance report: Vol. 29. Cases of HIV infection and AIDS in the United States. 2017 [accessed 2019 May 20]. http://www.cdc.gov/hiv/library/reports/hiv-surveillance.html.
  • Chhatre S, Metzger DS, Frank I, Boyer J, Thompson E, Nidich S, Montaner LJ, Jayadevappa R. 2013. Effects of behavioral stress reduction Transcendental Meditation intervention in persons with HIV. AIDS Care. 25(10):1291–1297.
  • Corless IB, Lindgren T, Holzemer W, Robinson L, Moezzi S, Kirksey K, Coleman C, Tsai Y-F, Sanzero Eller L, Hamilton MJ, et al. 2009. Marijuana effectiveness as an HIV self-care strategy. Clin Nurs Res. 18(2):172–193.
  • Cristiani SA, Pukay-Martin ND, Bornstein RA. 2004. Marijuana use and cognitive function in HIV-infected people. J Neuropsychiatry Clin Neurosci. 16(3):330–335.
  • D’Souza G, Matson P, Grady CD, Nahvi W, Merenstein D, Weber KM, Greenblatt R, Burian P, Wilson TE. 2012. Medicinal and recreational marijuana use among HIV-infected women in the Women’s Interagency HIV Cohort (WIHS), 1994–2010. JAIDS. 61(5):618–626.
  • DeJong BC, Prentiss D, McFarland W, Machekano R, Israelski DM. 2005. Marijuana use and its association with adherence to antiretroviral therapy among HIV-infected persons with moderate to severe nausea. JAIDS. 38(1):43–46.
  • Ellis RJ, Toperoff W, Vaida F, van den Brande G, Gonzales J, Gouaux B, Bentley H, Atkinson JH. 2009. Smoked medicinal cannabis for neuropathic pain in HIV: A randomized crossover clinical trial. Neuropsychopharmacol. 34(3):672–680.
  • Farris SG, Metrik J, Bonn-Miller MO, Kahler CW, Zvolensky MJ. 2016. Anxiety sensitivity and distress intolerance as predictors of cannabis dependence symptoms, problems, and craving: the mediating role of coping motives. J Stud Alcohol Drugs. 77(6):889–897.
  • Feinstein BA, & Newcomb ME. 2016. The role of substance use motives in the associations between minority stressors and substance use problems among young men who have sex with men. Psychol Sex Orientat Gend Divers. 3(3):357–366.
  • Fogarty A, Rawstorne P, Prestage G, Crawford J, Grierson J, Kippax S. 2007. Marijuana as therapy for people living with HIV/AIDS: social and health aspects. AIDS Care. 19(2):295–301.
  • Furler MD, Einarson TR, Millson M, Walmsley S, Bendayan R. 2004. Medicinal and recreational marijuana use by patients infected with HIV. AIDS Patient Care Stds. 18(4):215–227.
  • Gayner B, Esplen MJ, DeRoche P, Wong J, Bishop S, Kavanagh L, Butler K. 2012. A randomized controlled trial of mindfulness-based stress reduction to manage affective symptoms and improve quality of life in gay men living with HIV. J Behav Med. 35(3):272–285.
  • Gonzalez A, Barinas J, O'Cleirigh C. 2011. Substance use: Impact on adherence and HIV medical treatment. Curr HIV/AIDS Rep. 8(4):223–234.
  • Green B, Kavanagh D, Young R. 2003. Being stoned: a review of self-reported cannabis effects. Drug Alcohol Rev. 22(4):453–460.
  • Harris GE, Dupuis L, Mugford GJ, Johnston L, Haase D, Page G, Haldane H, Harris N, Midodzi WK, Dow G. 2014. Patterns and correlates of cannabis use among individuals with HIV/AIDS in Maritime Canada. Can J Infect Dis Med Microbiol. 25(1):e1–e7.
  • Hyman SM, Sinha R. 2009. Stress-related factors in cannabis use and misuse: Implications for prevention and treatment. J Subst Abuse Treat. 36(4):400–413.
  • Jacobus J, Bava S, Cohen-Zio M, Mahmood O, Tapert SF. 2009. Functional consequences of marijuana use in adolescents. Pharmacol Biochem Behav. 92(4):559–565.
  • Kipp AM, Rebeiro PF, Shepherd BE, Brinkley-Rubinstein L, Turner M, Bebawy S, Sterling TR, Hulgan T. 2017. Daily marijuana use is associated with missed clinic appointments among HIV-infected persons engaged in HIV care. AIDS Behav. 21(7):1996–2004.
  • Kristjansson SD, Agrawal A, Lynskey MT, Chassin LA. 2012. Marijuana expectancies and relationships with adolescent and adult marijuana use. Drug Alcohol Depend. 126(1–2):102–110.
  • Lake S, Kerr T, Capler R, Shoveller J, Montaner J, Milloy M-J. 2017. High-intensity cannabis use and HIV clinical outcomes among HIV-positive people who use illicit drugs in Vancouver, Canada. Int J Drug Policy. 42:63–70.
  • Lin LA, Ilgen MA, Jannausch M, Bohnert KM. 2016. Comparing adults who use cannabis medically with those who use recreationally: Results from a national sample. Addict Behav. 61:99–103.
  • Locke GR 3rd, Weaver AL, Melton LJ 3rd, Talley NJ. 2004. Psychosocial factors are linked to functional gastrointestinal disorders: a population based nested case-control study. Am J Gastroenterol. 99(2): 350–7.
  • Lubman DI, Cheetham A, Yücel M. 2015. Cannabis and adolescent brain development. Pharmacol Ther. 148:1–16.
  • Manning K, Paulus DJ, Hogan JB, Buckner JD, Farris SG, Zvolensky MJ. 2018. Negative affectivity as a mechanism underlying perceived distress tolerance and cannabis use problems, barriers to cessation, and self-efficacy for quitting among urban cannabis users. Addict Behav. 78:216–222.
  • Miles MB, Huberman AM. 1994. Qualitative Data Analysis: An Expanded Sourcebook. Thousand Oaks, CA: Sage.
  • National Academy of Sciences, Engineering, and Medicine. 2017. The Health Effects of Cannabis and Cannabinoids: The Current State of Evidence and Recommendations for Research. Washington DC: National Academies Press.
  • Okafor CN, Zhou Z, Burrell LE, Kelso NE, Whitehead NE, Harman JS, Cook CL, Cook RL. 2017. Marijuana use and viral suppression in persons receiving medical care for HIV infection. Am J Drug Alcohol Abuse. 43(1):103–110.
  • Osborne GB, Fogel C. 2008. Understanding the motivations for recreational marijuana use among adult Canadians. Subst Use Misuse. 43(3–4):539–572.
  • Pacek LR, Towe SL, Hobkirk AL, Nash D, Goodwin RD. 2018. Frequency of cannabis use and medical cannabis use among persons living with HIV in the United States: Findings from a nationally representative sample. AIDS Educ Prev. 30(2):169–181.
  • Pedersen W. 2015. From badness to illness: Medical cannabis and self-diagnosed attention deficit hyperactivity disorder. Addict Res Theory. 23(3):177–186.
  • Prentiss D, Power R, Balmas G, Tzuang G, Israelski DM. 2004. Patterns of marijuana use among patients with HIV/AIDS followed in a public health care setting. J Acquir Immune Defic Syndr. 35(1):38–45.
  • Robinson FP, Mathews HL, Witek-Janusek L. 2000. Stress Reduction and HIV Disease: A Review of Intervention Studies Using a Psychoneuroimmunology Framework. J Assoc Nurses AIDS Care. 11(2):87–96.
  • Sandberg S. 2012. Is cannabis use normalized, celebrated or neutralized? Analysing talk as action. Addict Res Theory. 20(5):372–381.
  • Schulenberg JE, Johnston LD, O’Malley P, Bachman JG, Miech RA, Patrick ME. 2017. Monitoring the Future national survey results on drug use, 1975-2016: Vol. II, college students and adults ages 19-55. Ann Arbor: Institute for Social Research, The University of Michigan. http://monitoringthefuture.org/pubs.html#monographs.
  • Shiffman S, Wills TA. 1985. Coping and Substance Use. Orlando, FL: Academic Press.
  • Silins E, Horwood LJ, Patton GC, Fergusson DM, Olsson CA, Hutchinson DM, Spry E, Toumbourou JW, Degenhardt L, Swift W, et al. 2014. Young adult sequelae of adolescent cannabis use: an integrative analysis. Lancet Psychiatry. 1(4):286–293.
  • Simons J, Correia CJ, Carey KB, Borsari B. 1998. Validating a five-factor marijuana motives measure: Relations with use, problems, and alcohol motives. J Couns Psychol. 45(3):265–273.
  • Slawson G, Milloy M-J, Balneaves L, Simo A, Guillemi S, Hogg R, Montaner J, Wood E, Kerr T. 2015. High-intensity cannabis use and adherence to antiretroviral therapy among people who use illicit drugs in a Canadian setting. AIDS Behav. 19(1):120–127.
  • Stewart DW, Shamdasani PN. 1990. Focus Groups: Theory and Practice. Newbury Park (CA): Sage.
  • Strauss A, Corbin J. 1998. Basics of Qualitative Research: Thousand Oaks, CA: Sage.
  • Tapert SF, Schweinsburg AD, Brown SA. 2008. The influence of marijuana use on neurocognitive functioning in adolescents. Curr Drug Abuse Rev. 1(1):99–111.
  • Towe SL, Horton OE, Martin B, Meade CS. 2018. A comparison of motivations for marijuana use in HIV-positive and HIV-negative adults. AIDS Behav. 22(9):2807–2814.
  • Volkow ND, Baler RD, Compton WM, Weiss S. 2014. Adverse health effects of marijuana use. N Engl J Med. 370(23):2219–2227.
  • Ware MA, Rueda S, Singer J, Kilby D. 2003. Cannabis use by persons living with HIV/AIDS: Patterns and prevalence of use. J Cannabis Therapeutics. 3(2):3–15.
  • Whiting PF, Wolff RF, Deshpande S, Di Nisio M, Duffy S, Hernandez AV, Keurentjes JC, Lang S, Misso K, Ryder S, et al. 2015. Cannabinoids for medical use: A systematic review and meta-analysis. J Amer Med Assoc. 313(24):2456–2473.
  • Zvolensky MJ, Vujanovic AA, Bernstein A, Bonn-Miller MO, Marshall EC, Leyro TM. 2007. Marijuana use motives: A confirmatory test and evaluation among young adult marijuana users. Addict Behav. 32(12):3122–3130.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.